Q1 FY27 results: standalone profit up 28%, revenue up 6% YoY

Pat Growth 25pctResults View source PDF Explain this filing

GSPCROP · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.2%Reaction day

₹591.50

prior close

₹592.20

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.4%-0.5% vs market

Pesticides & Agrochemicals peers, median of 28sector-1.1%+0.9% vs sector

On the reaction day the stock moved 0.5 pts less than Nifty Microcap 250 and 0.9 pts more than its Pesticides & Agrochemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.4

10m

-0.4

15m

-0.3

30m

-0.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.2+0.4-0.5-1.1+0.9

Next day

+0.6+0.5+0.1-1.9+2.5

+0.4+0.6-0.2-2.3+2.8

-0.9+0.7-1.7-2.3+1.4

-0.3+1.1-1.4-3.2+2.9

-0.4+0.5-0.9-3.3+2.9

+0.1+1.3-1.2-2.8+3.0

15d

+5.5+0.5+5.0-4.0+9.5

-20.2-0.8-19.4-6.3-13.9

-19.7-0.9-18.7-11.3-8.4

—————

UpDownMarket · Nifty Microcap 250Sector · Pesticides & Agrochemicals peers, median of 28Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

GSP Crop Science posted Q1 FY27 (quarter ended June 30, 2026) standalone revenue of Rs 4,242 million, up about 6% YoY, and net profit of Rs 312.82 million, up about 28% YoY. EPS stood at Rs 6.72 versus Rs 6.24 earlier. Consolidated revenue was Rs 3,859.95 million with net profit of Rs 263.94 million. Auditor review was clean with no qualifications. IPO proceeds fully utilised. Board set AGM for September 18, 2026 with record date September 11, 2026 for dividend eligibility.

Likely market impact

Strong profit growth on steady revenue signals healthy earnings momentum. Record date set for dividend eligibility.